How do you navigate ASA and CAP rules on Botox and prescription treatments?
Under Section 12 of the UK CAP Code and MHRA guidance, advertising prescription-only medicines (POMs) — including botulinum toxin — directly to consumers on social media is strictly prohibited. Doing so risks ASA adjudications, clinic account shadowbans, or permanent profile deletion. Chéri Social designs compliant organic strategies: focusing on clinician expertise, medical consultation frameworks, facial anatomy education, and general rejuvenation outcomes without naming prescription products on public feeds.
